BRCA2 and posterior cortical atrophy: A Gallagher et al. study reported that BRCA2 mutation carriers had an increased risk of PCa and a higher histologic grade, and BRCA1 or BRCA2 mutations were associated with a more aggressive clinical course [31], findings confirmed by studies by Castro et al. in a large retrospective cohort [47].